Dechra Pharmaceuticals (DPH)

 

DPH Share PerformanceMore

52 week high1,711.0 15/03/17
52 week low811.0 24/06/16
52 week change 473.0 (38.90%)
4 week volume3,930,760 03/03/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Additional Listing

RNS Number: 1994A Dechra Pharmaceuticals PLC 23 March 2017 23 March 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) Additional Listing An application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 80,000 ordinary shares of 1 pence each (the "Shares") to be admitted to the Official List. These Sha...

Director Deals - Dechra Pharmaceuticals PLC (DPH)

Tony Griffin, Executive Director, sold 3,500 shares in the company on the 21st March 2017 at a price of 1676.00p. The Direct...

Director/PDMR Shareholding

RNS Number: 1005A Dechra Pharmaceuticals PLC 21 March 2017 21 March 2017 Dechra Pharmaceuticals PLC (the Company) Director Shareholding Dechra Pharmaceuticals PLC has been notified that on 21 March 2017 Anthony Griffin, Executive Director, sold 3,500 ordinary shares in the Company at a price of 16.76 each. Following this acquisition, Anthony Griffi...

Director Declaration

RNS Number: 8560Z Dechra Pharmaceuticals PLC 17 March 2017 17 March 2017 Dechra Pharmaceuticals PLC ("Dechra" or "the Company") Director's Declaration In accordance with Listing Rule 9.6.14(2) Dechra announces that Ishbel Macpherson, Non-Executive Director of Dechra, is to be appointed as a Non-Executive Director of Fidessa group plc with effect from...

Block listing Interim Review

RNS Number: 5358Z Dechra Pharmaceuticals PLC 15 March 2017 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically and provided to an ris . Date: 15 March 2017 Name of applicant: Dechra Pharmaceuticals PLC Name of scheme: Long-Term Incentive Scheme Period of return: From: 15 September...

Broker Forecast - RBC Capital Markets issues a broker note on Dechra Pharmaceuticals PLC

RBC Capital Markets today reaffirms its outperform investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and ...

Director/PDMR Shareholding

RNS Number: 7791Y Dechra Pharmaceuticals PLC 07 March 2017 7 March 2017 Dechra Pharmaceuticals PLC (the Company) Director Shareholding The Company announces that on 7 March 2017 Richard Cotton, Chief Financial Officer, was granted the following awards over ordinary shares of 1 pence each in the Company. Each award will vest, subject to the satis...

Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today reaffirms its hold investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised ...

Fundamental DataMore

P/E ratio120.643
EPS14
Dividend yield1.093 %

Equity Research (DPH)

edison investment research
Dechra Pharmaceuticals plc
10/09/2015
Dechra Pharmaceuticals delivered FY15 revenue growth of 10% CER to £203.5m and EPS growth of 16.9% from 36.3p to 39.9p, with strong sales performances in its Companion Animal Products (CAP) segment,...
edison investment research
Dechra Pharmaceuticals plc
08/07/2015
Dechra Pharmaceuticals’ medium-term outlook is underpinned by a sharpened portfolio focus, new product launches and geographic expansion. Solid performances on these fronts in FY15 have overcome the...
edison investment research
Dechra Pharmaceuticals plc
29/04/2015
Dechra Pharmaceuticals has delivered another solid quarter with revenue growth up 6.0% (14.3% CER), resulting in nine-month growth of 6.6% (12.3% CER). Although boosted by phasing of pre-Easter...

Latest discussion posts More

  • RBC Cap Markets....

    say buy DPH ....target price #18.9
    14-Mar-2017
    valeite
  • Stonking results

    The number which impressed me most was net cash inflow from operating activities .... it was almost the same for the first half of the current year as it was for the whole of ...
    27-Feb-2017
    LK Hyman
  • Re: Kate Burgess ...

    Cudnt, What an uplifting article! It's good that not all CEOs come up through the traditional varsity, MBA route. I didn't know that Dechra is getting into farm animals. ...
    19-Dec-2016
    LK Hyman

Users' HoldingsMore

Users who hold Dechra Pharmaceuticals also hold..
NATIONAL GRID45%
DIAGEO38%
LLOYDS GRP.30%
PZ CUSSONS26%
SHIRE24%

Codes & Symbols

ISINGB0009633180
SymbolsDPH, LSE:DPH, DPH.L, DPH:LN, LON:DPH, XLON:DPH